Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate the efficacy of LAF237 in patients with type 2 diabetes with HbA1c 9- 11% by testing the hypothesis that the HbA1c reduction with LAF237 50 mg BID is superior to that with LAF 237 50 mg OD after 12 weeks of treatment.
Inclusion criteria
- Diabetes Mellitus